InsiderDB
Sign inStart free trial

Alnylam Pharmaceuticals (ALNY)

Healthcare · Biotechnology

4 members of Congress have disclosed 7 trades in Alnylam Pharmaceuticals (ALNY) since 2023: 2 buys and 5 sales. The most recent was disclosed on Sep 9, 2026.

Trades disclosed
7
Members trading
4
Buys / sells
2 / 5
Reported value
$49K–$210K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow ALNY

What else is happening at ALNY

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. ALNYCompany announcement·SEC EDGAR

    ALNY: Leadership change · Other company developments

    Filed 8-K for an event or period dated 2026-11-02. Leadership change; Other company developments.

    Public: Nov 5, 2026, 7:37 AM ESTEvent / period: Nov 2, 2026Original source ↗
  2. ALNYFinancial report·SEC EDGAR

    ALNY: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 8:20 AM EDTEvent / period: Sep 30, 2026Original source ↗
  3. ALNYCompany announcement·SEC EDGAR

    ALNY: Financial results

    Filed 8-K for an event or period dated 2026-10-29. Financial results.

    Public: Oct 29, 2026, 8:16 AM EDTEvent / period: Oct 29, 2026Original source ↗
  4. ALNYLobbying report·Lobbying disclosures

    ALNY: third_quarter 2026 lobbying report

    Issues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act; issues related to MFN drig pricing Issues relating to supply chain tariffs Implementation of The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (PL 116-94); issues related to drug pricing; FY2026 Labor HHS appropriations, issues related to genetically targeted technologies; HR1672, Maintaining Investments in New Innovation Act.

    Public: Oct 20, 2026, 5:56 PM EDTOriginal source ↗
  5. ALNYLobbying report·Lobbying disclosures

    ALNY: third_quarter 2026 lobbying report

    RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; U.S. Competitiveness FDA modernization

    Public: Oct 20, 2026, 4:07 PM EDTOriginal source ↗

Who traded ALNY

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.